CovidSeniorV1, Main, Exploration, bibRecord, 000814

Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.

Identifieur interne : 000814 ( Main/Exploration ); précédent : 000813; suivant : 000815

Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.

Auteurs : Anas Hamadeh [États-Unis] ; Ali Aldujeli [Lituanie] ; Kasparas Briedis [Lituanie] ; Kristen M. Tecson [États-Unis] ; Jorge Sanz-Sánchez [Italie] ; Montazar Al Dujeili [Italie] ; Ammar Al-Obeidi [Iraq] ; Jose Luís Diez [Espagne] ; Remigijus Žali Nas [Lituanie] ; Robert C. Stoler [États-Unis] ; Peter A. Mccullough [États-Unis]

Source :

The American journal of cardiology [ 1879-1913 ] ; 2020.

RBID : pubmed:32732010

Descripteurs français

KwdFr :
- Adulte d'âge moyen (MeSH), Betacoronavirus (MeSH), Coronarographie (MeSH), Espagne (épidémiologie), Femelle (MeSH), Fibrinolytiques (usage thérapeutique), Humains (MeSH), Incidence (MeSH), Infarctus du myocarde avec sus-décalage du segment ST (complications), Infarctus du myocarde avec sus-décalage du segment ST (diagnostic), Infarctus du myocarde avec sus-décalage du segment ST (thérapie), Infections à coronavirus (complications), Infections à coronavirus (épidémiologie), Intervention coronarienne percutanée (méthodes), Italie (épidémiologie), Mâle (MeSH), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (épidémiologie), Résultat thérapeutique (MeSH), Sujet âgé (MeSH), Taux de survie (tendances), Traitement thrombolytique (méthodes), Études de suivi (MeSH), Études rétrospectives (MeSH).
MESH :
- diagnostic : Infarctus du myocarde avec sus-décalage du segment ST.
- méthodes : Intervention coronarienne percutanée, Traitement thrombolytique.
- tendances : Taux de survie.
- thérapie : Infarctus du myocarde avec sus-décalage du segment ST.
- usage thérapeutique : Fibrinolytiques, Infarctus du myocarde avec sus-décalage du segment ST, Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Espagne, Infections à coronavirus, Italie, Pneumopathie virale.
- Adulte d'âge moyen, Betacoronavirus, Coronarographie, Femelle, Humains, Incidence, Mâle, Pandémies, Résultat thérapeutique, Sujet âgé, Études de suivi, Études rétrospectives.
Wicri :
- geographic : Italie, Espagne.

English descriptors

KwdEn :
- Aged (MeSH), Betacoronavirus (MeSH), Coronary Angiography (MeSH), Coronavirus Infections (complications), Coronavirus Infections (epidemiology), Female (MeSH), Fibrinolytic Agents (therapeutic use), Follow-Up Studies (MeSH), Humans (MeSH), Incidence (MeSH), Italy (epidemiology), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Percutaneous Coronary Intervention (methods), Pneumonia, Viral (complications), Pneumonia, Viral (epidemiology), Retrospective Studies (MeSH), ST Elevation Myocardial Infarction (complications), ST Elevation Myocardial Infarction (diagnosis), ST Elevation Myocardial Infarction (therapy), Spain (epidemiology), Survival Rate (trends), Thrombolytic Therapy (methods), Treatment Outcome (MeSH).
MESH :
- chemical , therapeutic use : Fibrinolytic Agents.
- geographic , epidemiology : Italy, Spain.
- complications : Coronavirus Infections, Pneumonia, Viral, ST Elevation Myocardial Infarction.
- diagnosis : ST Elevation Myocardial Infarction.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- methods : Percutaneous Coronary Intervention, Thrombolytic Therapy.
- therapy : ST Elevation Myocardial Infarction.
- trends : Survival Rate.
- Aged, Betacoronavirus, Coronary Angiography, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Pandemics, Retrospective Studies, Treatment Outcome.

Abstract

There is limited information regarding clinical characteristics and outcomes of patients with SARS-CoV-2 (COVID-19) disease presenting with ST-segment elevation myocardial infarction (STEMI). In this multicenter retrospective study, we reviewed charts of patients admitted with symptomatic COVID-19 infection and STEMI to a total of 4 hospitals spanning Italy, Lithuania, Spain and Iraq from February 1, 2020 to April 15, 2020. A total of 78 patients were included in this study, 49 (63%) of whom were men, with a median age of 65 [58, 71] years, and high comorbidity burden. During hospitalization, 8 (10%) developed acute respiratory distress syndrome, and 14 (18%) required mechanical ventilation. 19 (24%) patients were treated with primary Percutaneous Coronary Intervention (PCI) and 59 (76%) were treated with fibrinolytic therapy. 13 (17%) patients required cardiac resuscitation, and 9 (11%) died. For the 19 patients treated with primary PCI, 8 (42%) required intubation and 8 (42%) required cardiac resuscitation; stent thrombosis occurred in 4 patients (21%). A total of 5 patients (26%) died during hospitalization. 50 (85%) of the 59 patients initially treated with fibrinolytic therapy had successful fibrinolysis. The median time to reperfusion was 27 minutes [20, 34]. Hemorrhagic stroke occurred in 5 patients (9%). Six patients (10%) required invasive mechanical ventilation; 5 (9%) required cardiac resuscitation, and 4 (7%) died. In conclusion, this is the largest case series to-date of COVID-19 positive patients presenting with STEMI and spans 4 countries. We found a high rate of stent thrombosis, indicating a possible need to adapt STEMI management for COVID-19 patients.

DOI: 10.1016/j.amjcard.2020.06.063
PubMed: 32732010
PubMed Central: PMC7333635

Affiliations:

Espagne, Iraq, Italie, Lituanie, États-Unis
Texas

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000911
to stream Main, to step Curation: 000911

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.</title>
<author><name sortKey="Hamadeh, Anas" sort="Hamadeh, Anas" uniqKey="Hamadeh A" first="Anas" last="Hamadeh">Anas Hamadeh</name>
<affiliation wicri:level="2"><nlm:affiliation>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas, Texas. Electronic address: Anas.Hamadeh@bswhealth.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Aldujeli, Ali" sort="Aldujeli, Ali" uniqKey="Aldujeli A" first="Ali" last="Aldujeli">Ali Aldujeli</name>
<affiliation wicri:level="1"><nlm:affiliation>Lithuanian University of Health Sciences, Kaunas, Lithuania.</nlm:affiliation>
<country xml:lang="fr">Lituanie</country>
<wicri:regionArea>Lithuanian University of Health Sciences, Kaunas</wicri:regionArea>
<wicri:noRegion>Kaunas</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Briedis, Kasparas" sort="Briedis, Kasparas" uniqKey="Briedis K" first="Kasparas" last="Briedis">Kasparas Briedis</name>
<affiliation wicri:level="1"><nlm:affiliation>Lithuanian University of Health Sciences, Kaunas, Lithuania.</nlm:affiliation>
<country xml:lang="fr">Lituanie</country>
<wicri:regionArea>Lithuanian University of Health Sciences, Kaunas</wicri:regionArea>
<wicri:noRegion>Kaunas</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tecson, Kristen M" sort="Tecson, Kristen M" uniqKey="Tecson K" first="Kristen M" last="Tecson">Kristen M. Tecson</name>
<affiliation wicri:level="2"><nlm:affiliation>Baylor Heart and Vascular Institute, Dallas, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor Heart and Vascular Institute, Dallas</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sanz Sanchez, Jorge" sort="Sanz Sanchez, Jorge" uniqKey="Sanz Sanchez J" first="Jorge" last="Sanz-Sánchez">Jorge Sanz-Sánchez</name>
<affiliation wicri:level="1"><nlm:affiliation>Humanitas Clinical and Research Center IRCCS, Rozzano-Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Humanitas Clinical and Research Center IRCCS, Rozzano-Milan</wicri:regionArea>
<wicri:noRegion>Rozzano-Milan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Al Dujeili, Montazar" sort="Al Dujeili, Montazar" uniqKey="Al Dujeili M" first="Montazar" last="Al Dujeili">Montazar Al Dujeili</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Brescia, Brescia, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>University of Brescia, Brescia</wicri:regionArea>
<wicri:noRegion>Brescia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Al Obeidi, Ammar" sort="Al Obeidi, Ammar" uniqKey="Al Obeidi A" first="Ammar" last="Al-Obeidi">Ammar Al-Obeidi</name>
<affiliation wicri:level="1"><nlm:affiliation>Al-Kafeel Super specialty hospital, Karbala, Iraq; Karbala cardiac and cardiosurgical center, Karbala, Iraq.</nlm:affiliation>
<country xml:lang="fr">Iraq</country>
<wicri:regionArea>Al-Kafeel Super specialty hospital, Karbala, Iraq; Karbala cardiac and cardiosurgical center, Karbala</wicri:regionArea>
<wicri:noRegion>Karbala</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Diez, Jose Luis" sort="Diez, Jose Luis" uniqKey="Diez J" first="Jose Luís" last="Diez">Jose Luís Diez</name>
<affiliation wicri:level="1"><nlm:affiliation>Hospital Universitario y Politécnico La Fe, Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitario y Politécnico La Fe, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zali Nas, Remigijus" sort="Zali Nas, Remigijus" uniqKey="Zali Nas R" first="Remigijus" last="Žali Nas">Remigijus Žali Nas</name>
<affiliation wicri:level="1"><nlm:affiliation>Lithuanian University of Health Sciences, Kaunas, Lithuania.</nlm:affiliation>
<country xml:lang="fr">Lituanie</country>
<wicri:regionArea>Lithuanian University of Health Sciences, Kaunas</wicri:regionArea>
<wicri:noRegion>Kaunas</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stoler, Robert C" sort="Stoler, Robert C" uniqKey="Stoler R" first="Robert C" last="Stoler">Robert C. Stoler</name>
<affiliation wicri:level="2"><nlm:affiliation>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mccullough, Peter A" sort="Mccullough, Peter A" uniqKey="Mccullough P" first="Peter A" last="Mccullough">Peter A. Mccullough</name>
<affiliation wicri:level="2"><nlm:affiliation>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas, Texas; Baylor Heart and Vascular Institute, Dallas, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas, Texas; Baylor Heart and Vascular Institute, Dallas</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32732010</idno>
<idno type="pmid">32732010</idno>
<idno type="doi">10.1016/j.amjcard.2020.06.063</idno>
<idno type="pmc">PMC7333635</idno>
<idno type="wicri:Area/Main/Corpus">000911</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000911</idno>
<idno type="wicri:Area/Main/Curation">000911</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000911</idno>
<idno type="wicri:Area/Main/Exploration">000911</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.</title>
<author><name sortKey="Hamadeh, Anas" sort="Hamadeh, Anas" uniqKey="Hamadeh A" first="Anas" last="Hamadeh">Anas Hamadeh</name>
<affiliation wicri:level="2"><nlm:affiliation>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas, Texas. Electronic address: Anas.Hamadeh@bswhealth.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Aldujeli, Ali" sort="Aldujeli, Ali" uniqKey="Aldujeli A" first="Ali" last="Aldujeli">Ali Aldujeli</name>
<affiliation wicri:level="1"><nlm:affiliation>Lithuanian University of Health Sciences, Kaunas, Lithuania.</nlm:affiliation>
<country xml:lang="fr">Lituanie</country>
<wicri:regionArea>Lithuanian University of Health Sciences, Kaunas</wicri:regionArea>
<wicri:noRegion>Kaunas</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Briedis, Kasparas" sort="Briedis, Kasparas" uniqKey="Briedis K" first="Kasparas" last="Briedis">Kasparas Briedis</name>
<affiliation wicri:level="1"><nlm:affiliation>Lithuanian University of Health Sciences, Kaunas, Lithuania.</nlm:affiliation>
<country xml:lang="fr">Lituanie</country>
<wicri:regionArea>Lithuanian University of Health Sciences, Kaunas</wicri:regionArea>
<wicri:noRegion>Kaunas</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tecson, Kristen M" sort="Tecson, Kristen M" uniqKey="Tecson K" first="Kristen M" last="Tecson">Kristen M. Tecson</name>
<affiliation wicri:level="2"><nlm:affiliation>Baylor Heart and Vascular Institute, Dallas, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor Heart and Vascular Institute, Dallas</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sanz Sanchez, Jorge" sort="Sanz Sanchez, Jorge" uniqKey="Sanz Sanchez J" first="Jorge" last="Sanz-Sánchez">Jorge Sanz-Sánchez</name>
<affiliation wicri:level="1"><nlm:affiliation>Humanitas Clinical and Research Center IRCCS, Rozzano-Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Humanitas Clinical and Research Center IRCCS, Rozzano-Milan</wicri:regionArea>
<wicri:noRegion>Rozzano-Milan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Al Dujeili, Montazar" sort="Al Dujeili, Montazar" uniqKey="Al Dujeili M" first="Montazar" last="Al Dujeili">Montazar Al Dujeili</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Brescia, Brescia, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>University of Brescia, Brescia</wicri:regionArea>
<wicri:noRegion>Brescia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Al Obeidi, Ammar" sort="Al Obeidi, Ammar" uniqKey="Al Obeidi A" first="Ammar" last="Al-Obeidi">Ammar Al-Obeidi</name>
<affiliation wicri:level="1"><nlm:affiliation>Al-Kafeel Super specialty hospital, Karbala, Iraq; Karbala cardiac and cardiosurgical center, Karbala, Iraq.</nlm:affiliation>
<country xml:lang="fr">Iraq</country>
<wicri:regionArea>Al-Kafeel Super specialty hospital, Karbala, Iraq; Karbala cardiac and cardiosurgical center, Karbala</wicri:regionArea>
<wicri:noRegion>Karbala</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Diez, Jose Luis" sort="Diez, Jose Luis" uniqKey="Diez J" first="Jose Luís" last="Diez">Jose Luís Diez</name>
<affiliation wicri:level="1"><nlm:affiliation>Hospital Universitario y Politécnico La Fe, Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitario y Politécnico La Fe, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zali Nas, Remigijus" sort="Zali Nas, Remigijus" uniqKey="Zali Nas R" first="Remigijus" last="Žali Nas">Remigijus Žali Nas</name>
<affiliation wicri:level="1"><nlm:affiliation>Lithuanian University of Health Sciences, Kaunas, Lithuania.</nlm:affiliation>
<country xml:lang="fr">Lituanie</country>
<wicri:regionArea>Lithuanian University of Health Sciences, Kaunas</wicri:regionArea>
<wicri:noRegion>Kaunas</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stoler, Robert C" sort="Stoler, Robert C" uniqKey="Stoler R" first="Robert C" last="Stoler">Robert C. Stoler</name>
<affiliation wicri:level="2"><nlm:affiliation>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mccullough, Peter A" sort="Mccullough, Peter A" uniqKey="Mccullough P" first="Peter A" last="Mccullough">Peter A. Mccullough</name>
<affiliation wicri:level="2"><nlm:affiliation>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas, Texas; Baylor Heart and Vascular Institute, Dallas, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas, Texas; Baylor Heart and Vascular Institute, Dallas</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">The American journal of cardiology</title>
<idno type="eISSN">1879-1913</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Coronary Angiography (MeSH)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Female (MeSH)</term>
<term>Fibrinolytic Agents (therapeutic use)</term>
<term>Follow-Up Studies (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Incidence (MeSH)</term>
<term>Italy (epidemiology)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Percutaneous Coronary Intervention (methods)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Retrospective Studies (MeSH)</term>
<term>ST Elevation Myocardial Infarction (complications)</term>
<term>ST Elevation Myocardial Infarction (diagnosis)</term>
<term>ST Elevation Myocardial Infarction (therapy)</term>
<term>Spain (epidemiology)</term>
<term>Survival Rate (trends)</term>
<term>Thrombolytic Therapy (methods)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Coronarographie (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Fibrinolytiques (usage thérapeutique)</term>
<term>Humains (MeSH)</term>
<term>Incidence (MeSH)</term>
<term>Infarctus du myocarde avec sus-décalage du segment ST (complications)</term>
<term>Infarctus du myocarde avec sus-décalage du segment ST (diagnostic)</term>
<term>Infarctus du myocarde avec sus-décalage du segment ST (thérapie)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Intervention coronarienne percutanée (méthodes)</term>
<term>Italie (épidémiologie)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Taux de survie (tendances)</term>
<term>Traitement thrombolytique (méthodes)</term>
<term>Études de suivi (MeSH)</term>
<term>Études rétrospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Fibrinolytic Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Italy</term>
<term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>ST Elevation Myocardial Infarction</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>ST Elevation Myocardial Infarction</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infarctus du myocarde avec sus-décalage du segment ST</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Percutaneous Coronary Intervention</term>
<term>Thrombolytic Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Intervention coronarienne percutanée</term>
<term>Traitement thrombolytique</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Taux de survie</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>ST Elevation Myocardial Infarction</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Infarctus du myocarde avec sus-décalage du segment ST</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Survival Rate</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Fibrinolytiques</term>
<term>Infarctus du myocarde avec sus-décalage du segment ST</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term>
<term>Infections à coronavirus</term>
<term>Italie</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Betacoronavirus</term>
<term>Coronary Angiography</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Retrospective Studies</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Betacoronavirus</term>
<term>Coronarographie</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Italie</term>
<term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">There is limited information regarding clinical characteristics and outcomes of patients with SARS-CoV-2 (COVID-19) disease presenting with ST-segment elevation myocardial infarction (STEMI). In this multicenter retrospective study, we reviewed charts of patients admitted with symptomatic COVID-19 infection and STEMI to a total of 4 hospitals spanning Italy, Lithuania, Spain and Iraq from February 1, 2020 to April 15, 2020. A total of 78 patients were included in this study, 49 (63%) of whom were men, with a median age of 65 [58, 71] years, and high comorbidity burden. During hospitalization, 8 (10%) developed acute respiratory distress syndrome, and 14 (18%) required mechanical ventilation. 19 (24%) patients were treated with primary Percutaneous Coronary Intervention (PCI) and 59 (76%) were treated with fibrinolytic therapy. 13 (17%) patients required cardiac resuscitation, and 9 (11%) died. For the 19 patients treated with primary PCI, 8 (42%) required intubation and 8 (42%) required cardiac resuscitation; stent thrombosis occurred in 4 patients (21%). A total of 5 patients (26%) died during hospitalization. 50 (85%) of the 59 patients initially treated with fibrinolytic therapy had successful fibrinolysis. The median time to reperfusion was 27 minutes [20, 34]. Hemorrhagic stroke occurred in 5 patients (9%). Six patients (10%) required invasive mechanical ventilation; 5 (9%) required cardiac resuscitation, and 4 (7%) died. In conclusion, this is the largest case series to-date of COVID-19 positive patients presenting with STEMI and spans 4 countries. We found a high rate of stent thrombosis, indicating a possible need to adapt STEMI management for COVID-19 patients.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32732010</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1913</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>131</Volume>
<PubDate><Year>2020</Year>
<Month>09</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The American journal of cardiology</Title>
<ISOAbbreviation>Am J Cardiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.</ArticleTitle>
<Pagination><MedlinePgn>1-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0002-9149(20)30641-X</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjcard.2020.06.063</ELocationID>
<Abstract><AbstractText>There is limited information regarding clinical characteristics and outcomes of patients with SARS-CoV-2 (COVID-19) disease presenting with ST-segment elevation myocardial infarction (STEMI). In this multicenter retrospective study, we reviewed charts of patients admitted with symptomatic COVID-19 infection and STEMI to a total of 4 hospitals spanning Italy, Lithuania, Spain and Iraq from February 1, 2020 to April 15, 2020. A total of 78 patients were included in this study, 49 (63%) of whom were men, with a median age of 65 [58, 71] years, and high comorbidity burden. During hospitalization, 8 (10%) developed acute respiratory distress syndrome, and 14 (18%) required mechanical ventilation. 19 (24%) patients were treated with primary Percutaneous Coronary Intervention (PCI) and 59 (76%) were treated with fibrinolytic therapy. 13 (17%) patients required cardiac resuscitation, and 9 (11%) died. For the 19 patients treated with primary PCI, 8 (42%) required intubation and 8 (42%) required cardiac resuscitation; stent thrombosis occurred in 4 patients (21%). A total of 5 patients (26%) died during hospitalization. 50 (85%) of the 59 patients initially treated with fibrinolytic therapy had successful fibrinolysis. The median time to reperfusion was 27 minutes [20, 34]. Hemorrhagic stroke occurred in 5 patients (9%). Six patients (10%) required invasive mechanical ventilation; 5 (9%) required cardiac resuscitation, and 4 (7%) died. In conclusion, this is the largest case series to-date of COVID-19 positive patients presenting with STEMI and spans 4 countries. We found a high rate of stent thrombosis, indicating a possible need to adapt STEMI management for COVID-19 patients.</AbstractText>
<CopyrightInformation>Copyright © 2020 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hamadeh</LastName>
<ForeName>Anas</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas, Texas. Electronic address: Anas.Hamadeh@bswhealth.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Aldujeli</LastName>
<ForeName>Ali</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Lithuanian University of Health Sciences, Kaunas, Lithuania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Briedis</LastName>
<ForeName>Kasparas</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Lithuanian University of Health Sciences, Kaunas, Lithuania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tecson</LastName>
<ForeName>Kristen M</ForeName>
<Initials>KM</Initials>
<AffiliationInfo><Affiliation>Baylor Heart and Vascular Institute, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sanz-Sánchez</LastName>
<ForeName>Jorge</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Humanitas Clinical and Research Center IRCCS, Rozzano-Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Al Dujeili</LastName>
<ForeName>Montazar</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>University of Brescia, Brescia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Al-Obeidi</LastName>
<ForeName>Ammar</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Al-Kafeel Super specialty hospital, Karbala, Iraq; Karbala cardiac and cardiosurgical center, Karbala, Iraq.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Diez</LastName>
<ForeName>Jose Luís</ForeName>
<Initials>JL</Initials>
<AffiliationInfo><Affiliation>Hospital Universitario y Politécnico La Fe, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Žaliūnas</LastName>
<ForeName>Remigijus</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Lithuanian University of Health Sciences, Kaunas, Lithuania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stoler</LastName>
<ForeName>Robert C</ForeName>
<Initials>RC</Initials>
<AffiliationInfo><Affiliation>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>McCullough</LastName>
<ForeName>Peter A</ForeName>
<Initials>PA</Initials>
<AffiliationInfo><Affiliation>Baylor University Medical Center, Dallas, Texas; Baylor Scott and White Heart and Vascular Hospital, Dallas, Texas; Baylor Heart and Vascular Institute, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>07</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Am J Cardiol</MedlineTA>
<NlmUniqueID>0207277</NlmUniqueID>
<ISSNLinking>0002-9149</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017023" MajorTopicYN="N">Coronary Angiography</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D062645" MajorTopicYN="N">Percutaneous Coronary Intervention</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="N">ST Elevation Myocardial Infarction</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>05</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>06</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>06</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>8</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>8</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32732010</ArticleId>
<ArticleId IdType="pii">S0002-9149(20)30641-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.amjcard.2020.06.063</ArticleId>
<ArticleId IdType="pmc">PMC7333635</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
<li>Iraq</li>
<li>Italie</li>
<li>Lituanie</li>
<li>États-Unis</li>
</country>
<region><li>Texas</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Texas"><name sortKey="Hamadeh, Anas" sort="Hamadeh, Anas" uniqKey="Hamadeh A" first="Anas" last="Hamadeh">Anas Hamadeh</name>
</region>
<name sortKey="Mccullough, Peter A" sort="Mccullough, Peter A" uniqKey="Mccullough P" first="Peter A" last="Mccullough">Peter A. Mccullough</name>
<name sortKey="Stoler, Robert C" sort="Stoler, Robert C" uniqKey="Stoler R" first="Robert C" last="Stoler">Robert C. Stoler</name>
<name sortKey="Tecson, Kristen M" sort="Tecson, Kristen M" uniqKey="Tecson K" first="Kristen M" last="Tecson">Kristen M. Tecson</name>
</country>
<country name="Lituanie"><noRegion><name sortKey="Aldujeli, Ali" sort="Aldujeli, Ali" uniqKey="Aldujeli A" first="Ali" last="Aldujeli">Ali Aldujeli</name>
</noRegion>
<name sortKey="Briedis, Kasparas" sort="Briedis, Kasparas" uniqKey="Briedis K" first="Kasparas" last="Briedis">Kasparas Briedis</name>
<name sortKey="Zali Nas, Remigijus" sort="Zali Nas, Remigijus" uniqKey="Zali Nas R" first="Remigijus" last="Žali Nas">Remigijus Žali Nas</name>
</country>
<country name="Italie"><noRegion><name sortKey="Sanz Sanchez, Jorge" sort="Sanz Sanchez, Jorge" uniqKey="Sanz Sanchez J" first="Jorge" last="Sanz-Sánchez">Jorge Sanz-Sánchez</name>
</noRegion>
<name sortKey="Al Dujeili, Montazar" sort="Al Dujeili, Montazar" uniqKey="Al Dujeili M" first="Montazar" last="Al Dujeili">Montazar Al Dujeili</name>
</country>
<country name="Iraq"><noRegion><name sortKey="Al Obeidi, Ammar" sort="Al Obeidi, Ammar" uniqKey="Al Obeidi A" first="Ammar" last="Al-Obeidi">Ammar Al-Obeidi</name>
</noRegion>
</country>
<country name="Espagne"><noRegion><name sortKey="Diez, Jose Luis" sort="Diez, Jose Luis" uniqKey="Diez J" first="Jose Luís" last="Diez">Jose Luís Diez</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000814 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000814 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidSeniorV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32732010
   |texte=   Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32732010" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidSeniorV1

This area was generated with Dilib version V0.6.37.
Data generation: Thu Oct 15 09:49:45 2020. Site generation: Wed Jan 27 17:10:23 2021

	Serveur d'exploration sur la COVID chez les séniors
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la COVID chez les séniors

Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.

Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki